Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-02 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −7,790 194,750
2021-02-01 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-02-01 RUBINSTEIN JULIE President Sale −10,945 $55.36 $606K 4,055
2021-02-01 RUBINSTEIN JULIE President Sale −4,055 $56.01 $227K 0
2021-02-01 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 80,000
2021-02-01 ROBINS HARLAN S Chief Scientific Officer Option exercise +7,790 $6.32 $49K 8,469
2021-02-01 ROBINS HARLAN S Chief Scientific Officer Sale −4,200 $55.54 $233K 4,269
2021-02-01 ROBINS HARLAN S Chief Scientific Officer Sale −3,590 $56.18 $202K 679
2021-02-01 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −7,790 202,540
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 2,604
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 5,208
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise +1,562 $7.27 $11K 6,770
2021-02-01 BENZENO SHARON Chief Business Development Off Sale −6,470 $55.61 $360K 300
2021-02-01 BENZENO SHARON Chief Business Development Off Sale −300 $56.41 $17K 0
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 23,438
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 52,084
2021-02-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −1,562 35,938
2021-01-29 Taylor Stacy L SVP and General Counsel Option exercise +1,042 $7.80 $8K 2,342
2021-01-29 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 4,113
2021-01-29 Taylor Stacy L SVP and General Counsel Sale −1,095 $55.71 $61K 3,018

Page 64 of 120 · 2,386 trades